Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study (NCT05065840)
Implementing an Evidence-Based, Multilevel Intervention to Promote HPV Vaccination Among HIV Positive Adults
🩺 Plain-English Summary (8th-Grade Level)
People living with HIV (PLWH) are 28 times more likely to be diagnosed with Human Papillomavirus (HPV) - associated anal cancer than the general population. The HPV vaccine is an effective and safe approach to prevent and reduce the risk of HPV-related disease among PLWH. HPV vaccine programs tailored and implemented in the HIV population are lagging for this high-risk group. The CDC's 4 Pillars Transformation Program is a multi-level, evidence-based intervention that has been successfully used to increase HPV vaccination in the general population and is ready to be tested in the high-risk HIV population, particularly PLWH in the rural South. This program offers providers and clinic staff evidence-based strategies to increase HPV vaccination uptake via training and educational resources. This study proposes to tailor and refine the 4 Pillars Program and conduct this project in three HIV clinics in Georgia.
Who can join: Review the eligibility criteria below.
Location: Albany Rural Model Clinic — Albany, Georgia
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
- CDC 4 Pillars Program (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- Albany Rural Model Clinic — Albany, Georgia
- AID Atlanta — Atlanta, Georgia
- Faebris — Atlanta, Georgia
- AHF Lithonia — Lithonia, Georgia
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Human Papilloma Virus
- TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers — Chicago, Illinois
- Impact of Standing Orders Optimization — Chapel Hill, North Carolina
- Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Among Children 4 to 8 Years Old — Boston, Massachusetts
- Impact of Financial Incentives — Chapel Hill, North Carolina
- Single Visit Clinical Validation of ScreenFire, a Low-cost HPV Test — San Salvador,
Explore by condition: All Human Papilloma Virus clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.